Literature DB >> 34058014

Differences in risk factors for molecular subtypes of clear cell renal cell carcinoma.

Mark P Purdue1, Jongeun Rhee1, Lee Moore1, Xiaohua Gao2, Xuezheng Sun2, Erin Kirk2, Vladimir Bencko3, Vladimir Janout4, Dana Mates5, David Zaridze6, Stacey Petruzella7, Abraham Ari Hakimi7, William Marston Linehan8, Stephen J Chanock1, Paul Brennan9, Helena Furberg7, Melissa Troester2, Nathaniel Rothman1.   

Abstract

The ccA and ccB molecular subtypes of clear cell renal cell carcinoma (ccRCC) have well-characterized prognostic relevance. However, it is not known whether they possess distinct etiologies. We investigated the relationships between these subtypes and RCC risk factors within a case-control study conducted in Eastern Europe. We analyzed risk factor data for ccA (n = 144) and ccB (n = 106) cases and 1476 controls through case-only and case-control comparisons to assess risk factor differences across subtypes using logistic and polytomous regression models. We also performed a meta-analysis summarizing case-only results from our study and three patient cohorts. Patients with ccB tumors had poorer survival than those with ccA tumors and were more likely to be male (case-only odds ratio [OR] 2.68, 95% confidence interval [CI] 1.43-5.03). In case-control analyses, body mass index was significantly associated with ccA tumors (OR 2.45, 95% CI 1.18-5.10 for ≥35 vs <25 kg/m2 ) but not with ccB tumors (1.52, 0.56-4.12), while trichloroethylene was associated with ccB but not ccA (OR 3.09, 95% CI 1.11-8.65 and 1.25, 0.36-4.39 respectively for ≥1.58 ppm-years vs unexposed). A polygenic risk score of genetic variants identified from genome-wide association studies was associated with both ccA and, in particular, ccB (OR 1.82, 1.11-2.99 and 2.87, 95% CI 1.64-5.01 respectively for 90th vs 10th percentile). In a meta-analysis of case-only results including three patient cohorts, we still observed the ccB excess for male sex and the ccA excess for obesity. In conclusion, our findings suggest the existence of etiologic heterogeneity across ccRCC molecular subtypes for several risk factors.
© 2021 Union for International Cancer Control. This article has been contributed to by US Government employees and their work is in the public domain in the USA.

Entities:  

Keywords:  case-control study; clear cell renal cell carcinoma; epidemiology; molecular pathology; risk factors

Mesh:

Year:  2021        PMID: 34058014      PMCID: PMC8628648          DOI: 10.1002/ijc.33701

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.316


  25 in total

1.  Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns.

Authors:  A Rose Brannon; Anupama Reddy; Michael Seiler; Alexandra Arreola; Dominic T Moore; Raj S Pruthi; Eric M Wallen; Matthew E Nielsen; Huiqing Liu; Katherine L Nathanson; Börje Ljungberg; Hongjuan Zhao; James D Brooks; Shridar Ganesan; Gyan Bhanot; W Kimryn Rathmell
Journal:  Genes Cancer       Date:  2010-02-01

Review 2.  Renal cancer subtypes: Should we be lumping or splitting for therapeutic decision making?

Authors:  Scott M Haake; W Kimryn Rathmell
Journal:  Cancer       Date:  2016-11-14       Impact factor: 6.860

3.  Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants.

Authors:  Lee E Moore; Paolo Boffetta; Sara Karami; Paul Brennan; Patricia S Stewart; Rayjean Hung; David Zaridze; Vsevolod Matveev; Vladimir Janout; Helena Kollarova; Vladimir Bencko; Marie Navratilova; Neonila Szeszenia-Dabrowska; Dana Mates; Jan Gromiec; Ivana Holcatova; Maria Merino; Stephen Chanock; Wong-Ho Chow; Nathaniel Rothman
Journal:  Cancer Res       Date:  2010-07-27       Impact factor: 12.701

4.  Oral Contraceptive Use and Risks of Cancer in the NIH-AARP Diet and Health Study.

Authors:  Kara A Michels; Louise A Brinton; Ruth M Pfeiffer; Britton Trabert
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

Review 5.  Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations.

Authors:  Zachary Klinghoffer; Brian Yang; Anil Kapoor; Jehonathan H Pinthus
Journal:  Expert Rev Anticancer Ther       Date:  2009-07       Impact factor: 4.512

6.  Intrinsic Genomic Differences Between African American and White Patients With Clear Cell Renal Cell Carcinoma.

Authors:  Bhavani Krishnan; Tracy L Rose; Jordan Kardos; Matthew I Milowsky; William Y Kim
Journal:  JAMA Oncol       Date:  2016-05-01       Impact factor: 31.777

7.  Comprehensive molecular characterization of clear cell renal cell carcinoma.

Authors: 
Journal:  Nature       Date:  2013-06-23       Impact factor: 49.962

8.  Aristolochic acid exposure in Romania and implications for renal cell carcinoma.

Authors:  Robert J Turesky; Byeong Hwa Yun; Paul Brennan; Dana Mates; Viorel Jinga; Patricia Harnden; Rosamonde E Banks; Helene Blanche; Marie-Therese Bihoreau; Priscilia Chopard; Louis Letourneau; G Mark Lathrop; Ghislaine Scelo
Journal:  Br J Cancer       Date:  2015-12-10       Impact factor: 7.640

9.  Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC).

Authors:  Christopher J Ricketts; W Marston Linehan
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

10.  An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma.

Authors:  A Ari Hakimi; Helena Furberg; Emily C Zabor; Anders Jacobsen; Nikolaus Schultz; Giovanni Ciriello; Nina Mikklineni; Brandon Fiegoli; Philip H Kim; Martin H Voss; Hui Shen; Peter W Laird; Chris Sander; Victor E Reuter; Robert J Motzer; James J Hsieh; Paul Russo
Journal:  J Natl Cancer Inst       Date:  2013-11-27       Impact factor: 13.506

View more
  1 in total

1.  MicroRNA Processing Pathway-Based Polygenic Score for Clear Cell Renal Cell Carcinoma in the Volga-Ural Region Populations of Eurasian Continent.

Authors:  Elizaveta Ivanova; Irina Gilyazova; Valentin Pavlov; Adel Izmailov; Galiya Gimalova; Alexandra Karunas; Inga Prokopenko; Elza Khusnutdinova
Journal:  Genes (Basel)       Date:  2022-07-20       Impact factor: 4.141

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.